Table 3.

Mean dN/dS ratio comparisons within the HVR1 for progressors (cases) and nonprogressors (controls)



dN/dS ratio
Time point
Progressors
Nonprogressors
P for difference between progressors and nonprogressors
Early dN/dS ratio   2.02 (SE, 0.70)   0.98 (SE, 0.22)   .25  
Late dN/dS ratio   0.62 (SE, 0.22)   0.98 (SE, 0.39)   .52  
Mean difference (early to late) in dN/dS ratio   -1.40 (SE, 0.83)   -0.006 (SE, 0.55)   .31  
P for difference over time
 
.13
 
.99
 

 


dN/dS ratio
Time point
Progressors
Nonprogressors
P for difference between progressors and nonprogressors
Early dN/dS ratio   2.02 (SE, 0.70)   0.98 (SE, 0.22)   .25  
Late dN/dS ratio   0.62 (SE, 0.22)   0.98 (SE, 0.39)   .52  
Mean difference (early to late) in dN/dS ratio   -1.40 (SE, 0.83)   -0.006 (SE, 0.55)   .31  
P for difference over time
 
.13
 
.99
 

 

The numbers of synonymous mutations (dS) and the numbers of nonsynonymous mutations (dN) were determined using the Nei-Gojobori method with the Jukes-Cantor correction for multiple substitutions.22  The mean dN/dS ratio, a measure of selective pressure, was calculated for each patient. One matched pair is excluded due to a shift in dominant subtype in the progressor. Progressors demonstrated an overall decrease in dN/dS ratio over time, whereas nonprogressors remain stable.

Close Modal

or Create an Account

Close Modal
Close Modal